CAMBRIDGE, Mass.--(Organization WIRE)--Jan 14, 2021--Amylyx Pharmaceuticals, Inc., a pharmaceutical firm focused on producing new solutions for amyotrophic lateral sclerosis (ALS),...
Frates
The MarketWatch News Section was not included in the generation of this content. Amylyx Pharmaceuticals, Inc., a pharmaceutical firm targeted...
